HighTower Advisors
RDY icon

HighTower Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

HighTower Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$569K Buy
39,276
+5,018
+15% +$67.7K ﹤0.01% 2626
2026
Q1 		$474K Buy
34,258
+19,659
+135% +$274K ﹤0.01% 2768
2025
Q4 		$205K Sell
14,599
-2,011
-12% -$28.2K ﹤0.01% 3356
2025
Q3 		$232K Buy
16,610
+2,982
+22% +$42.9K ﹤0.01% 3241
2025
Q2 		$205K Sell
13,628
-1,849
-12% -$26.4K ﹤0.01% 3261
2025
Q1 		$204K Sell
15,477
-14,445
-48% -$199K ﹤0.01% 3169
2024
Q4 		$472K Buy
+29,922
New +$450K ﹤0.01% 2519
2023
Q3 		– Sell
-138,745
Closed -$1.75M – 3721
2023
Q2 		$1.75M Buy
+138,745
New +$1.62M ﹤0.01% 1426
2020
Q2 		– Sell
-198,780
Closed -$1.61M – 2519
2020
Q1 		$1.61M Buy
+198,780
New +$1.66M 0.01% 820
2019
Q1 		– Sell
-40,655
Closed -$305K – 2399
2018
Q4 		$305K Buy
+40,655
New +$286K ﹤0.01% 1594
2017
Q1 		– Sell
-73,365
Closed -$667K – 2150
2016
Q4 		$667K Sell
73,365
-1,735
-2% -$16.1K 0.01% 1143
2016
Q3 		$698K Sell
75,100
-88,955
-54% -$849K 0.01% 1074
2016
Q2 		$1.71M Sell
164,055
-6,650
-4% -$60.9K 0.02% 675
2016
Q1 		$1.56M Buy
+170,705
New +$1.53M 0.01% 825
2015
Q4 		– Sell
-196,100
Closed -$2.48M – 2123
2015
Q3 		$2.48M Sell
196,100
-1,730
-0.9% -$21.5K 0.03% 541
2015
Q2 		$2.18M Buy
197,830
+57,975
+41% +$640K 0.04% 514
2015
Q1 		$1.6M Buy
139,855
+1,875
+1% +$19.9K 0.02% 659
2014
Q4 		$1.39M Buy
137,980
+19,650
+17% +$207K 0.02% 697
2014
Q3 		$1.24M Buy
118,330
+27,590
+30% +$259K 0.02% 699
2014
Q2 		$783K Buy
90,740
+24,040
+36% +$202K 0.01% 900
2014
Q1 		$586K Buy
+66,700
New +$580K 0.01% 924
2013
Q3 		– Sell
-59,325
Closed -$589K – 1432
2013
Q2 		$589K Buy
+59,325
New +$433K 0.02% 752

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HighTower Advisors's RDY Position: Q2 2026 in Review

HighTower Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 15% in Q2 2026, buying an estimated $67.7K and bringing the position to 39,276 shares worth $569K. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

HighTower Advisors first reported a position in RDY in Q2 2013 and has held it in 22 quarters since. The position peaked at $2.48M in Q3 2015. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • HighTower Advisors held 39,276 shares of Dr. Reddy's Laboratories worth $569K as of Q2 2026.
  • HighTower Advisors bought 5,018 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $67.7K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2626 holding.
  • HighTower Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 22 quarters since.
  • HighTower Advisors's Dr. Reddy's Laboratories position peaked at $2.48M in Q3 2015.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.